BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 3490498)

  • 41. Guidelines for Speech Recording and Acoustic Analyses in Dysarthrias of Movement Disorders.
    Rusz J; Tykalova T; Ramig LO; Tripoliti E
    Mov Disord; 2021 Apr; 36(4):803-814. PubMed ID: 33373483
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interarticulator coordination in dysarthria: an X-ray microbeam study.
    Weismer G; Yunusova Y; Westbury JR
    J Speech Lang Hear Res; 2003 Oct; 46(5):1247-61. PubMed ID: 14575356
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differences between Subjective and Objective Assessment of Speech Deficiency in Parkinson Disease.
    Pawlukowska W; Szylińska A; Kotlęga D; Rotter I; Nowacki P
    J Voice; 2018 Nov; 32(6):715-722. PubMed ID: 29122413
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The physical significance of acoustic parameters and its clinical significance of dysarthria in Parkinson's disease.
    Yang S; Wang F; Yang L; Xu F; Luo M; Chen X; Feng X; Zou X
    Sci Rep; 2020 Jul; 10(1):11776. PubMed ID: 32678256
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ataxic dysarthria.
    Kent RD; Kent JF; Duffy JR; Thomas JE; Weismer G; Stuntebeck S
    J Speech Lang Hear Res; 2000 Oct; 43(5):1275-89. PubMed ID: 11063247
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of temporal alterations on speech intelligibility in parkinsonian dysarthria.
    Hammen VL; Yorkston KM; Minifie FD
    J Speech Hear Res; 1994 Apr; 37(2):244-53. PubMed ID: 8028306
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characteristics of the dysarthria of multiple system atrophy.
    Kluin KJ; Gilman S; Lohman M; Junck L
    Arch Neurol; 1996 Jun; 53(6):545-8. PubMed ID: 8660157
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Temporal acoustic measures of dysarthria associated with amyotrophic lateral sclerosis.
    Caruso AJ; Burton EK
    J Speech Hear Res; 1987 Mar; 30(1):80-7. PubMed ID: 3560901
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Functional brain imaging in pure akinesia with gait freezing: [18F] FDG PET and [18F] FP-CIT PET analyses.
    Park HK; Kim JS; Im KC; Oh SJ; Kim MJ; Lee JH; Chung SJ; Lee MC
    Mov Disord; 2009 Jan; 24(2):237-45. PubMed ID: 18951539
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Subcortical damage and cortical dysfunction in progressive supranuclear palsy demonstrated by positron emission tomography.
    Karbe H; Grond M; Huber M; Herholz K; Kessler J; Heiss WD
    J Neurol; 1992 Feb; 239(2):98-102. PubMed ID: 1552311
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acquired dysarthria in childhood: an analysis of dysarthric features in relation to neurologic deficits.
    van Dongen HR; Arts WF; Yousef-Bak E
    Neurology; 1987 Feb; 37(2):296-9. PubMed ID: 3808312
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Language production in Parkinson's disease: acoustic and linguistic considerations.
    Illes J; Metter EJ; Hanson WR; Iritani S
    Brain Lang; 1988 Jan; 33(1):146-60. PubMed ID: 3342316
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [F-18 FDG PET in dementia].
    Ichiya Y
    Rinsho Hoshasen; 1989 Oct; 34(11):1337-41. PubMed ID: 2601095
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Towards an automatic evaluation of the dysarthria level of patients with Parkinson's disease.
    Vásquez-Correa JC; Orozco-Arroyave JR; Bocklet T; Nöth E
    J Commun Disord; 2018; 76():21-36. PubMed ID: 30149241
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mapping typical and hypokinetic dysarthric speech production network using a connected speech paradigm in functional MRI.
    Narayana S; Parsons MB; Zhang W; Franklin C; Schiller K; Choudhri AF; Fox PT; LeDoux MS; Cannito M
    Neuroimage Clin; 2020; 27():102285. PubMed ID: 32521476
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acoustic reflex measurement in adults with cerebral palsy and dysarthria.
    Schliesser HF; Deshayes IL
    Folia Phoniatr (Basel); 1982; 34(5):242-5. PubMed ID: 7173758
    [No Abstract]   [Full Text] [Related]  

  • 57. Pathophysiology of motor speech disorders (dysarthria).
    Hirose H
    Folia Phoniatr (Basel); 1986; 38(2-4):61-88. PubMed ID: 3527898
    [No Abstract]   [Full Text] [Related]  

  • 58. [18F-fluorodeoxyglucose positron emission tomography in Parkinson's disease].
    Arahata Y; Kato T; Tadokoro M; Sobue G
    Nihon Rinsho; 1997 Jan; 55(1):222-6. PubMed ID: 9014454
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reproducibility and variability of speech muscle activity in athetoid dysarthria of cerebral palsy.
    Neilson PD; O'Dwyer NJ
    J Speech Hear Res; 1984 Dec; 27(4):502-17. PubMed ID: 6521456
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assessment of disease severity in parkinsonism with fluorine-18-fluorodeoxyglucose and PET.
    Eidelberg D; Moeller JR; Ishikawa T; Dhawan V; Spetsieris P; Chaly T; Robeson W; Dahl JR; Margouleff D
    J Nucl Med; 1995 Mar; 36(3):378-83. PubMed ID: 7884498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.